Skip to main content

Jim Cramer says it's too soon to tell how GLP-1 weight loss drugs will affect food stocks

CNBC's Jim Cramer on Tuesday said it may be too soon to tell how GLP-1 diabetes and weight loss drugs will change food stocks.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.